 Guardion Health Sciences, Inc. Guardion or the Company GHSI, an ocular health sciences company that, among other things, develops, formulates, manufacture and distributes condition-specific medical foods supported by evidence-based protocols, and provides ocular testing, announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Capital Market Nasdaq notifying the Company that it has been granted an additional 180-day compliance period or until September 14, 2020, to regain compliance with the minimum 1.00 bid price per share requirement of Nasdaqs Marketplace Rule 5550a2 the Rule. If at any time before September 14, 2020, the bid price of the Companys common stock closes at 1.00 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Rule, and the matter will be closed. 